BlackRock’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,546,289
Closed -$4.71M 5562
2023
Q1
$4.71M Sell
2,546,289
-25,167
-1% -$46.6K ﹤0.01% 3578
2022
Q4
$2.85M Sell
2,571,456
-217,859
-8% -$242K ﹤0.01% 3901
2022
Q3
$6.53M Buy
2,789,315
+124,992
+5% +$292K ﹤0.01% 3565
2022
Q2
$8.07M Buy
2,664,323
+197,465
+8% +$598K ﹤0.01% 3532
2022
Q1
$16.8M Sell
2,466,858
-44,178
-2% -$300K ﹤0.01% 3214
2021
Q4
$21M Sell
2,511,036
-23,815
-0.9% -$199K ﹤0.01% 3187
2021
Q3
$18.8M Buy
2,534,851
+77,752
+3% +$578K ﹤0.01% 3261
2021
Q2
$16.7M Buy
2,457,099
+617,800
+34% +$4.2M ﹤0.01% 3352
2021
Q1
$18.9M Buy
1,839,299
+292,744
+19% +$3.01M ﹤0.01% 3162
2020
Q4
$10.8M Buy
1,546,555
+336,420
+28% +$2.35M ﹤0.01% 3249
2020
Q3
$9.88M Sell
1,210,135
-61,519
-5% -$502K ﹤0.01% 3146
2020
Q2
$8.77M Buy
1,271,654
+28,788
+2% +$199K ﹤0.01% 3195
2020
Q1
$5.9M Buy
1,242,866
+4,789
+0.4% +$22.7K ﹤0.01% 3222
2019
Q4
$10.8M Sell
1,238,077
-25,754
-2% -$225K ﹤0.01% 3170
2019
Q3
$4.21M Buy
1,263,831
+100,081
+9% +$333K ﹤0.01% 3490
2019
Q2
$5.76M Buy
1,163,750
+20,646
+2% +$102K ﹤0.01% 3452
2019
Q1
$7.09M Buy
1,143,104
+77,765
+7% +$482K ﹤0.01% 3243
2018
Q4
$3.59M Sell
1,065,339
-385,341
-27% -$1.3M ﹤0.01% 3466
2018
Q3
$9.43M Buy
1,450,680
+55,775
+4% +$363K ﹤0.01% 3230
2018
Q2
$10.7M Buy
1,394,905
+253,120
+22% +$1.94M ﹤0.01% 3178
2018
Q1
$25.5M Sell
1,141,785
-20,055
-2% -$448K ﹤0.01% 2619
2017
Q4
$14.8M Buy
1,161,840
+436,114
+60% +$5.56M ﹤0.01% 2909
2017
Q3
$11.3M Buy
725,726
+365,497
+101% +$5.7M ﹤0.01% 3056
2017
Q2
$5.05M Buy
360,229
+97,139
+37% +$1.36M ﹤0.01% 3422
2017
Q1
$5.79M Buy
+263,090
New +$5.79M ﹤0.01% 3312